Study design: This study examines the links between severity of whiplash associated disorder and costs and health outcomes Objective: The aim of this study was to estimate the economic costs and health state utilities associated with disability levels and recovery trajectories following acute whiplash injury.
Introduction
An acute whiplash injury (AWI) is a common soft-tissue injury often caused by motor vehicle collisions but also trips or falls resulting in a sudden jolt to the neck. The most common complaint following AWI is neck pain but people can also experience headaches, arm pain, tingling and numbness. The prevalence of whiplash associated disorders (WAD) is high and increasing worldwide, particularly within developed countries 1 . Previous studies have documented the total societal burden of WAD, with an annual cost to the UK economy of over £3.1 billion in 2002, primarily made up of health service costs and productivity losses 9 . High societal costs have also been reported in the USA ($9 billion 10 ) and Europe (€10 billion 1 ). There is also evidence on long-term health consequences, with 30-50% of people suffering reduced health-related quality of life (HRQoL) caused by chronic symptoms associated with WAD 11 . However, these studies present group level results, not considering individual patient characteristics and how they interact with costs and HRQoL 12 .
Evaluating the cost-effectiveness of possible interventions for WAD requires either prospectively collected patient-level data from a clinical trial/observational study, or the use of modelling techniques to simulate the costs and benefits of different interventions. These models often make use of estimates of patient-level costs and health utilities (preferencebased outcomes rooted in economic theory 13 ) from secondary data sources, stratified by
Participants not responding within one week were sent a reminder letter, with those still not responding called over the telephone to obtain the core outcome measure set (NDI and EQ-5D).
Since this study's focus was the economic costs and HRQoL outcomes associated with different disability levels and recovery trajectories, rather than evaluations of the effectiveness or cost-effectiveness of the interventions in the trial, all MINT participants were included in these analyses, regardless of trial allocation.
Data collection instruments
The NDI is a measure of neck pain related disability consisting of 10 questions measuring symptom severity and activity restriction, each scored from 0 (none) to 5 (severe). These are summed and doubled to give a total ranging from 0 to 100. Raw scores can be converted to a disability severity classification devised by Vernon et al, with scores of 8 or less corresponding to no disability, 10-28 mild disability, 30-48 moderate disability, 50-68 severe disability and greater than 68 complete disability 19 . These categorisations are a commonly used approach in analyses using of the NDI 20 . Multiple longitudinal NDI measurements can be converted into a categorisation of patient recovery trajectories defined by Sterling et al, with injuries classed as mild, moderate or chronic-severe 21 .
Participants completed resource use questionnaires at 4, 8 and 12 months, asking for details of all hospital inpatient, outpatient, and community healthcare and social services used, diagnostic tests undertaken and medications prescribed 14 . National unit costs (2009 prices, UK£) were applied to these data 22 , which were added to patient recorded expenditures on privately purchased healthcare to give total per patient societal costs 14 .
MINT contained two measures of HRQoL, the SF-12 and EQ-5D. From the SF-12, a six dimension health-state classification called the SF-6D can be constructed, containing questions on physical functioning, role limitations, social functioning, pain, mental health and vitality 23 . The SF-6D describes 7,500 health states with utility values, calculated using the standard gamble technique from 611 members of the UK general population, ranging from 0.345 to 1.0 24 .
The first five EQ-5D items form a health state classification system asking respondents to describe their mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Responses to each of these are divided into three ordinal levels: (1) no problems; (2) some/moderate problems; (3) severe/extreme problems, generating a total of 243 possible health states. Utility scores can be produced using a UK specific tariff 25 , calculated from a time trade-off study of 3,336 people from the UK general population, taking values between -0.594 and 1.0. Pre-injury utility values were not available for the MINT dataset and were therefore estimated from published general population health estimates, adjusted for age 26 .
Statistical Analysis
Descriptive statistics were estimated for economic costs and health state utilities. Regression modelling was then used to estimate relationships between WAD severity and costs/health state utilities, adjusting for age, sex and pre-injury utility. In healthcare cost data, a significant proportion of individuals will often incur no costs and, for those that do, the distribution of costs is often highly skewed, with a small number of individuals incurring costs considerably higher than the mean 27 . A two-part model was thus used, the first a logistic regression model for the probability of incurring any costs. The second part was a generalised linear model (GLM) for costs incurred conditional on the cost being greater than zero. A log link function in the GLM means parameters have a multiplicative effect on cost, helping to model the skewed distribution of the data 28 . Models were produced for costs over the first four months of the follow-up period (with disability severity at 4 months as a predictor), and for costs between months 8 and 12 (using disability severity at 12 months). Since it was not possible to disentangle intervention costs from standard care, treatment allocation at initial randomisation was added as a covariate.
Ordinary least squares (OLS) models for EQ-5D and SF-6D utility values (with injury severity, age, sex and pre-injury utility as covariates) were also produced. Utility scores at 4 months (acute injury) and 12 months (chronic injury) were regressed on disability severity.
However, such models allow for the prediction of values outside the range of the EQ-5D/SF-6D. A high proportion of respondents also gave responses implying perfect health (a utility score of 1.0), something difficult to estimate using OLS models 29 . One solution is censored regression, which remove predictions outside the range and can lead to a cluster of predictions at the limit of the range 30 . However, these models assume that utility data are censored at 1.0 (i.e. higher values are possible, we simply cannot measure them) whereas in reality 1.0 is a genuine upper bound. Thus, we produced similar two-part models for utilities
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as for cost data, with a logistic model for the probability of having a utility less than 1.0, followed by a GLM for total disutility, conditional on the utility score being less than 1.0. We did not include treatment allocation as a covariate, since any improvements in health from trial interventions should not affect the relationship between the different measures.
To make use of the longitudinal data available, total costs (the sum of the three follow-up periods) and quality-adjusted life-years (QALYs) (estimated using the area under the EQ-5D
utility curve, assuming linear interpolation between measurements) accumulated over the follow-up period were regressed on the Sterling trajectories defined above, including length of follow-up as a covariate to adjust for differential follow-up lengths between participants.
The model for total costs was a two-part model, including treatment allocation as a covariate, whilst that for QALYs was an OLS model, as there are no longer fixed upper and lower bounds on this value.
Statistical analyses were performed in R version 3.0.1 31 .
Sensitivity analysis
Baseline analyses of costs used a societal perspective, including all cost items collected in the study. Sensitivity analyses were conducted, running the same models but restricting to NHS and personal social services (PSS) costs, the perspective recommended for economic evaluations in England by the National Institute for Health and Care Excellence 22 .
Results
Descriptive statistics are presented in 32 . However, there were no significant differences (again at the 5% level) in WAD grade at presentation, baseline EQ-5D utility, baseline SF-6D utility or costs between people who later went on to become responders or non-responders. decline was more pronounced for NHS and PSS costs, which comprised 73.9% of total costs between baseline and 4 months, but only 51.8% between 8 and 12 months. Table 3 reports the two-part models for costs, where AIC-based model selection indicated the gamma family as the correct specification for the mean-variance relationship in the GLM.
Increasing disability levels were monotonically associated with an increased probability of incurring costs, and an increase in the total cost given that one was incurred. Average societal costs, given one was incurred, were similar at 4 and 12 months (£166.67 vs. £174.40 for a 40 year old woman in the intervention group with a baseline utility of 0.925 and no disability), but there was a considerably higher probability of incurring a cost during the first 4 months (0.564 vs. 0.195 for the same person as above). Table 4 presents the OLS regression models for utility scores. Disability levels were again highly significant predictors, with higher disability associated with lower utility scores (e.g.
complete disability was associated with an EQ-5D decrement of 0.899 at 4 months and 0.888 at 12 months compared to no disability). SF-6D scores were lower than EQ-5D scores for people with low levels of disability (0.856 vs. 0.948 at 4 months for the characteristics listed above), but considerably higher in people with higher levels of disability (0.543 vs. 0.039 for the same characteristics, but with complete disability). Table 5 summarises two-part models for the EQ-5D and SF-6D utility scores, respectively.
Again, a gamma variance function was selected for the GLM, except for the 4 month SF-6D model, where a Gaussian distribution was selected using the AICs. Again, greater disability is associated with an increase in the probability of the utility score being less than 1.0, and the magnitude of that deviation, with the impact greater on probability than magnitude. There is also evidence of a difference in utility scores between men and women, though this is only present with the SF-6D. 
Discussion
This article reports economic costs, health state utilities and QALY profiles associated with differing disability levels during the recovery period following AWI. It uses a large dataset from a randomised controlled trial (MINT), which followed people through the recovery process 14 . The longitudinal dataset made it possible to consider costs and QALYs over the entire follow-up period, as well as at individual time points. Appropriate adjustments were made to address specific complexities that arise when using regression models on cost and
HRQoL data.
The results show the considerable impact neck-related disability can have, both on costs (a 20
fold increase from the lowest to highest levels of disability) and health state utilities (an average drop of 0.9 in EQ-5D utility scores between those categories). Differences in cost captured the direct cost of managing the condition, indirect costs to the health system via the exacerbation of co-morbidities, and additional costs to the patients themselves. The sensitivity analyses, restricted to direct costs incurred by health and social care services, produced the same pattern of results.
There are differences between this and similar studies in other clinical areas 33, 34 . First, most such studies use clinically defined events or clinical severity measures as explanatory variables, whereas we use another patient-reported outcome measure (PROM), the NDI. This was driven by the prevalence of the NDI in trials of WAD 23 , but presents both advantages and disadvantages. There is growing acceptance of the importance of PROMs in trials, and of their usefulness as a robust way of reflecting patient perspectives 35, 36 . However, the reliance on patient completion leads to higher levels of missing data, which can both bias analyses and lead to difficulties in generalisation. One might expect participants in worse health to be less likely to return questionnaires, resulting in utilities appearing higher than is accurate, and
costs lower. However, there were no significant differences in our outcomes variables (EQ-5D utility, SF-6D utility, costs) between patients who went on to become responders and nonresponders.
Secondly, whilst two-part models are now accepted as a technique for modelling of cost data, their use for utilities has been less common. Nevertheless, it has been recognised both that a significant proportion of participants will be in a state of "full health" at any time point, and that changes in mean utility scores for a population can be significantly driven by the move towards/away from the "full health" state 37 . This effect is particularly noticeable with the EQ-5D, due to the large gap between the (11111) state (responding 1 to every question, the best possible health state) and that with the next highest utility score 38 . Thus two-part models, which explicitly accommodate the switch from "full health" to other states, are equally useful in dealing with health utilities as costs. Other, more complex regression methods such as beta regression have also been proposed, but there is little evidence that they lead to improvements in model fit 39 .
Thirdly, all the usual caveats concerning data from clinical trials also apply in this context 40 .
The study inclusion criteria mean the population may not be fully representative of the background population of WAD patients. However, since MINT was an extremely pragmatic trial, designed to reflect routine care as closely as possible, this should not be as significant a problem as with less representative trials. Finally, difference in healthcare practices and preference structures mean that the patterns of resource use (and thus cost), compensation payments and health utilities can vary considerably between different countries 41 . Thus, careful thought should be given to the necessary assumptions when applying these results to contexts outside of the UK healthcare system.
When considering correlations between initial disability and long term costs, it is important to note that the biological severity of the initial injury may not be the only cause. Other literature has suggested that patients may ascribe pre-existing or unrelated symptoms as being the effects of whiplash, thereby overestimating the impact of the event 42 . Further, there have long been concerns about the difficulties in defining injury mechanisms and disease categories in WAD, and the nature of the link between biological injury, high initial symptoms and long-term prognosis (e.g. patients with compensation claims and lawsuits have significantly worse long-term outcomes than those without, even when adjusting for initial severtity 42 ). However, since we have no reason to believe these effects would be greater in one arm of the trial than the other, they are unlikely to bias results derived from within trial comparisons.
Nevertheless, despite these limitations, this research should prove useful to both economists and health service researchers, by providing estimates of economic costs and preferencebased HRQoL outcomes associated with different disability levels and recovery trajectories following AWI. These estimates can be used as inputs when modelling the cost-effectiveness of interventions for the management of WAD, and the budgetary impact of those interventions. Table 3 -Two-part models for societal and NHS cost data, modelling probability of cost for an individual being greater than 0, and total cost given that cost is greater than 0 Table 5 -Two-part models for EQ-5D and SF-6D health state utilities, modelling probability that the utility of an individual is less than 1, and total disutility given the utility is less than 1 EQ-5D models Model 1 (4 months) Model 2 (12 months) Probability of disutility Disutility given utility < 1 -0.307*** (0.008) Length of follow-up 0.002*** (0.0001) Sample size 2256 *p value <0.05, **p value <0.01, ***p value <0.001. ϮThe reference case is a man, 36 years of age, receiving standard care, with a pre-injury utility of 0.9, following a mild recovery trajectory and being followed up for one year.
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